Clinical Trial Update: Intranasal Insulin for the Treatment of HAND [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring intranasal insulin for HIV-associated neurocognitive disorders was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Dementia
• Hiv-associated Cognitive Motor Complex

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV Dementia, HIV-Associated Cognitive Motor Complex | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-07-07